AMENDMENT NO. 4 TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • May 22nd, 2019 • Catalent, Inc. • Pharmaceutical preparations • New York
This CREDIT AGREEMENT (“Agreement”) is entered into as of May 20, 2014 (as amended by Amendment No. 1 on December 1, 2014, as further amended by Amendment No. 2 on December 9, 2016 and2016, as further amended by Amendment No. 3 on October 18, 2017 and as further amended by Amendment No. 4 on May 17, 2019), among CATALENT PHARMA SOLUTIONS, INC., a Delaware corporation (the “Borrower”), PTS INTERMEDIATE HOLDINGS LLC, a Delaware limited liability company (“Holdings”), MORGAN STANLEY SENIOR FUNDING, INC. JPMORGAN CHASE BANK, N.A. (as successor to the Former Agent (as defined below)), as Administrative Agent, Collateral Agent and, Swing Line Lender, MORGAN STANLEY SENIOR FUNDING, INC. and JPMORGAN CHASE BANK, N.A., and as an L/C IssuersIssuer, and each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 22nd, 2019 • Catalent, Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 17, 2019, is by and among Catalent, Inc., a Delaware corporation (the “Company”), and Green Equity Investors VII, L.P., a Delaware limited partnership, Green Equity Investors Side VII, L.P., a Delaware limited partnership, LGP Associates VII-A LLC, a Delaware limited liability company, and LGP Associates VII-B LLC, a Delaware limited liability company (collectively, on a several and not joint basis, the “Purchaser”). The Purchaser and any other Person who may become a party hereto pursuant to Section 11(c) are referred to individually as a “Shareholder” and collectively as the “Shareholders.”
STOCKHOLDERS’ AGREEMENT by and among CATALENT, INC., GREEN EQUITY INVESTORS VII, L.P., GREEN EQUITY INVESTORS SIDE VII, L.P., LGP ASSOCIATES VII-A LLC and LGP ASSOCIATES VII-B LLC Dated as of May 17, 2019Stockholders’ Agreement • May 22nd, 2019 • Catalent, Inc. • Pharmaceutical preparations • Delaware
STOCKHOLDERS’ AGREEMENT, dated as of May 17, 2019 (as may be amended from time to time, this “Agreement”), by and among Catalent, Inc., a Delaware corporation (the “Company”), and each of Green Equity Investors VII, L.P., a Delaware limited partnership (“Fund VII”), Green Equity Investors Side VII, L.P., a Delaware limited partnership (“Fund Side VII”), LGP Associates VII-A LLC, a Delaware limited liability company (“LGP VII-A”), and LGP Associates VII-B LLC, a Delaware limited liability company (“LGP VII-B”, and together with Fund VII, Fund Side VII and LGP VII-A, the “Initial Stockholder”). The obligations of the Initial Stockholder set forth in this Agreement shall be several and not joint among Fund VII, Fund Side VII, LGP VII-A and LGP VII-B and apportioned in percentages of 44.68269%, 52.79859%, 0.25248% and 2.26624%, respectively.
